Jadayel D, Matutes E, Dyer M J, Brito-Babapulle V, Khohkar M T, Oscier D, Catovsky D
Academic Department of Haematology and Cytogenetics, Institute of Cancer Research, London, UK.
Blood. 1994 Jun 15;83(12):3664-71.
The translocation t(11;14)(q13;q32) occurs in about 15% of patients with splenic lymphoma with villous lymphocytes (SLVL) or the closely related disorder lymphoplasmacytic lymphoma (LPL). To characterize the nature and frequency of rearrangements of the BCL-1 locus in SLVL/LPL and to document the effect of these genetic alterations on the expression of the cyclin D1 gene, we analyzed 22 cases of SLVL/LPL with defined cytogenetic abnormalities by both conventional electrophoresis (CE) and pulse-field gel electrophoresis (PFGE) and by Northern blotting. Four SLVL/LPL cases showed rearrangement of the BCL-1 locus. In two cases with t(11;14)(q13;q32), different breakpoints were identified; one mapped adjacent to the major translocation cluster (MTC) and the other within a 28-kb region telomeric of it. In a third case of SLVL with no cytogenetic abnormality of 11q13, a novel breakpoint approximately 100 kb centromeric of MTC was detected by PFGE. The fourth case, which had a normal karyotype, demonstrated rearrangement with a BCL-1 probe immediately telomeric of MTC. This case may have had a small deletion of 0.5 kb from within the BCL-1 locus. No rearrangement of the BCL-1 locus or within the cyclin D1 gene was detected by CE or PFGE in any of the remaining 18 SLVL/LPL samples. Northern blot analysis showed expression of a normal-sized cyclin D1 transcript in the two SLVL/LPL cases with t(11;14)(q13;q32). In cases that lacked a cytogenetically demonstrable t(11;14) translocation, no cyclin D1 transcript was detected. Analysis of the BCL-1 locus was also performed in three other cases of B-cell disorders with t(11;14)(q13;q32) detected cytogenetically. Two cases were analyzed by Southern blot and showed rearrangement of the BCL-1 locus. Expression of high-level normal-sized and/or truncated cyclin D1 transcript was also detected in these cases. These data show the importance of PFGE in the detection of rearrangements in the BCL-1 locus and show further the complexity of rearrangements in this locus.
易位t(11;14)(q13;q32)发生于约15%的伴有绒毛淋巴细胞的脾淋巴瘤(SLVL)或密切相关的疾病淋巴浆细胞淋巴瘤(LPL)患者中。为了明确SLVL/LPL中BCL-1基因座重排的性质和频率,并记录这些基因改变对细胞周期蛋白D1基因表达的影响,我们通过常规电泳(CE)和脉冲场凝胶电泳(PFGE)以及Northern印迹法分析了22例具有明确细胞遗传学异常的SLVL/LPL病例。4例SLVL/LPL病例显示BCL-1基因座重排。在2例t(11;14)(q13;q32)病例中,鉴定出不同的断点;一个定位于主要易位簇(MTC)附近,另一个位于其端粒方向28 kb区域内。在第3例11q13无细胞遗传学异常的SLVL病例中,通过PFGE检测到一个位于MTC着丝粒方向约100 kb处的新断点。第4例核型正常,显示与MTC紧邻端粒处的BCL-1探针发生重排。该病例可能在BCL-1基因座内有一个0.5 kb的小缺失。在其余18例SLVL/LPL样本中,通过CE或PFGE均未检测到BCL-1基因座或细胞周期蛋白D1基因内的重排。Northern印迹分析显示,2例t(11;14)(q13;q32)的SLVL/LPL病例中有正常大小的细胞周期蛋白D1转录本表达。在缺乏细胞遗传学可证实的t(11;14)易位的病例中,未检测到细胞周期蛋白D1转录本。对另外3例经细胞遗传学检测发现t(11;14)(q13;q32)的B细胞疾病病例也进行了BCL-1基因座分析。2例经Southern印迹分析显示BCL-1基因座重排。在这些病例中还检测到高水平的正常大小和/或截短的细胞周期蛋白D1转录本表达。这些数据显示了PFGE在检测BCL-1基因座重排中的重要性,并进一步显示了该基因座重排的复杂性。